Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
NexImmune (NEXI)
NASDAQ:NEXI
NexImmune (NEXI) Stock Price & Analysis
84 Followers
NEXI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.19 - $4.91
Previous Close$0.43
Volume125.82K
Average Volume (3M)266.32K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$45.86M
Total Debt (Recent Filing)$1.16M
Price to Earnings (P/E)-0.2
Beta2.60
Next EarningsMar 29, 2023
EPS Estimate-$0.53
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
EPS (TTM)-2.63
Shares Outstanding26,078,451
R-Squared0.16
Standard Deviation0.34
10 Day Avg. Volume124,466
30 Day Avg. Volume266,324
Price to Book (P/B)0.22
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-0.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusHold
Alpha-0.12
Number of Analyst Covering2
NexImmune News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NEXI FAQ
What was NexImmune’s price range in the past 12 months?
NexImmune lowest stock price was $0.19 and its highest was $4.91 in the past 12 months.
What is NexImmune’s market cap?
Currently, no data Available
When is NexImmune’s upcoming earnings report date?
NexImmune’s upcoming earnings report date is Mar 29, 2023 which is in 53 days.
How were NexImmune’s earnings last quarter?
NexImmune released its earnings results on Nov 14, 2022. The company reported -$0.6 earnings per share for the quarter, beating the consensus estimate of -$0.696 by $0.096.
Is NexImmune overvalued?
According to Wall Street analysts NexImmune’s price is currently Overvalued.
Does NexImmune pay dividends?
NexImmune does not currently pay dividends.
What is NexImmune’s EPS estimate?
NexImmune’s EPS estimate is -$0.53.
How many shares outstanding does NexImmune have?
NexImmune has 26,078,451 shares outstanding.
What happened to NexImmune’s price movement after its last earnings report?
NexImmune reported an EPS of -$0.6 in its last earnings report, beating expectations of -$0.696. Following the earnings report the stock price went down -4.255%.
Which hedge fund is a major shareholder of NexImmune?
Among the largest hedge funds holding NexImmune’s share is Slate Path Capital LP. It holds NexImmune’s shares valued at 512K.
---
NexImmune Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
―
―
Insider Transactions
Bought Shares
Worth $95.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 1.0%
Last 30 Days ▼ 0.6%
Last 30 Days ▼ 0.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-85.10%
12-Months-Change
Fundamentals
Return on Equity
-84.43%
Trailing 12-Months
Asset Growth
-44.83%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
NexImmune
NexImmune Inc is a clinical-stage biotechnology company engaged in developing immunotherapy to employ body's T cells to generate immune response that mimics natural biology. Its creates therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases.
---
Yield10 Bioscience
―
Diffusion Pharmaceuticals
―
Bio-Path Holdings
―
Theriva Biologics
―
Silo Pharma
―
---